Market Price

240.54 

-0.26 -0.1%

as of May 14 '21

52 Week Range:

161.11 315.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; immersive virtual reality and display system that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 7.65
8.16
11.39
11.89
13.35
17.09
growth rate 6.7% 39.6% 4.4% 12.3% 28.0%
Earnings BIT 3.01
4.18
-1.35
1.27
29.98
47.47
-18.04
growth rate 38.9% -100.0% 100.0% 2,253.5% 58.3% -100.0%
Avg.PE 1,477.94
1,256.76
3,304.00
715.54
584.70
137.14
681.19
growth rate -15.0% 162.9% -78.3% -18.3% -76.6% 396.7%
ROA 1.25
2.33
0.56
5.18
1.19
1.33
8.21
-2.11
growth rate 86.4% -76.0% 825.0% -77.0% 11.8% 517.3% -100.0%
ROE 0.98
5.94
1.40
1.60
10.67
-2.79
growth rate 506.1% -76.4% 14.3% 566.9% -100.0%
ROIC 0.98
5.94
1.40
1.60
9.03
-2.58
growth rate 506.1% -76.4% 14.3% 464.4% -100.0%
Cur. Ratio 3.93
5.54
8.68
7.37
7.41
6.22
5.09
5.83
growth rate 41.0% 56.7% -15.1% 0.5% -16.1% -18.2% 14.5%
Quick Ratio 1.69
3.46
6.35
4.93
5.28
4.28
3.24
3.58
growth rate 104.7% 83.5% -22.4% 7.1% -18.9% -24.3% 10.5%
Leverage 1.13
1.16
1.19
1.22
1.37
1.28
growth rate 2.7% 2.6% 2.5% 12.3% -6.6%
Balance Sheet Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 18.21
20.57
30.05
43.34
58.01
81.90
105.90
114.61
growth rate 13.0% 46.1% 44.2% 33.9% 41.2% 29.3% 8.2%
Acct.Payable 15.84
2.35
2.57
4.11
6.76
8.18
15.11
14.11
growth rate -85.2% 9.3% 60.1% 64.4% 21.0% 84.8% -6.6%
Cur.Assets 62.24
115.30
244.36
263.83
382.23
410.73
463.13
617.70
growth rate 85.3% 111.9% 8.0% 44.9% 7.5% 12.8% 33.4%
Total Assets 71.15
121.38
263.85
308.25
476.67
515.01
665.90
822.98
growth rate 70.6% 117.4% 16.8% 54.6% 8.0% 29.3% 23.6%
Cash 4.13
3.29
19.55
13.24
50.64
67.85
72.78
69.67
growth rate -20.4% 494.1% -32.3% 282.6% 34.0% 7.3% -4.3%
Inventory 27.07
33.45
56.76
73.01
94.90
115.74
152.99
219.53
growth rate 23.6% 69.7% 28.6% 30.0% 22.0% 32.2% 43.5%
Cur.Liabilities 15.84
20.82
28.15
35.80
51.58
66.06
91.05
105.93
growth rate 31.5% 35.2% 27.2% 44.1% 28.1% 37.8% 16.4%
Liabilities 22.99
22.28
31.33
41.71
76.26
92.59
180.29
185.20
growth rate -3.1% 40.6% 33.1% 82.8% 21.4% 94.7% 2.7%
LT Debt 6.00
26.75
27.07
growth rate 28.3% 1.2%
Equity -12.37
232.52
266.55
400.41
422.24
485.89
641.50
growth rate 100.0% 14.6% 50.2% 5.5% 15.1% 32.0%
Common Shares 25.00
25.00
25.00
14.00
33.00
35.00
36.00
36.00
36.00
growth rate 0.0% 0.0% -44.0% 135.7% 6.1% 2.9% 0.0% 0.0%
Cash Flow Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 0.80
3.89
5.47
13.64
12.53
9.60
22.11
24.76
growth rate 387.2% 40.8% 149.1% -8.1% -23.4% 130.2% 12.0%
Cash From OA -6.39
-20.69
-12.81
12.69
28.81
26.65
-33.24
growth rate 0.0% 0.0% 100.0% 127.0% -7.5% -100.0%
FCF per Share -0.82
-0.91
-0.38
0.22
0.32
-1.55
growth rate 0.0% 0.0% 100.0% 45.5% -100.0%
Sale Purchase of Stock 0.18
1.04
125.36
9.75
117.12
12.80
13.90
growth rate 482.0% 12,000.3% -92.2% 1,101.3% -89.1% 8.7%
FCF -4.00
-10.00
-28.00
-26.00
-2.00
19.00
5.00
-58.00
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% -73.7% -100.0%
Income Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 88.85
125.51
186.10
263.32
333.76
444.94
547.41
560.41
growth rate 41.3% 48.3% 41.5% 26.8% 33.3% 23.0% 2.4%
Op.Income 4.10
3.01
4.18
-1.35
1.27
29.98
47.47
-18.04
growth rate -26.6% 38.9% -100.0% 100.0% 2,253.5% 58.3% -100.0%
IBT -1.26
3.14
4.02
-0.87
1.05
-1.49
50.14
-38.02
growth rate 100.0% 28.2% -100.0% 100.0% -100.0% 100.0% -100.0%
Net Income 4.10
2.25
2.37
14.81
4.66
6.60
48.46
-15.70
growth rate -45.2% 5.4% 526.4% -68.6% 41.7% 634.1% -100.0%
EPS 0.08
0.04
-0.03
0.08
0.44
0.13
0.18
1.34
-0.44
growth rate -50.0% -100.0% 100.0% 450.0% -70.5% 38.5% 644.4% -100.0%
Gross Profit 57.88
82.84
124.06
170.83
217.14
292.53
371.96
356.58
growth rate 43.1% 49.8% 37.7% 27.1% 34.7% 27.2% -4.1%
R&D 14.08
15.58
18.03
23.88
31.66
36.17
51.72
87.55
growth rate 10.6% 15.7% 32.4% 32.6% 14.2% 43.0% 69.3%

Quarterly Statements

Item Name Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Earnings BIT 0.61
-17.65
-20.16
16.66
13.46
growth rate -100.0% 0.0% 100.0% -19.2%
Balance Sheet Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Acct.Receivable 103.96
97.61
112.82
114.61
126.42
growth rate -6.1% 15.6% 1.6% 10.3%
Acct.Payable 15.84
14.43
14.54
14.11
15.39
growth rate -8.9% 0.8% -3.0% 9.1%
Cur.Assets 453.74
575.90
590.20
617.70
635.13
growth rate 26.9% 2.5% 4.7% 2.8%
Total Assets 664.24
780.20
810.30
822.98
840.82
growth rate 17.5% 3.9% 1.6% 2.2%
Cash 72.46
134.38
80.12
69.67
55.63
growth rate 85.5% -40.4% -13.0% -20.2%
Inventory 166.15
183.44
191.55
219.53
245.32
growth rate 10.4% 4.4% 14.6% 11.8%
Cur.Liabilities 88.07
77.61
108.06
105.93
111.86
growth rate -11.9% 39.2% -2.0% 5.6%
Liabilities 176.12
157.04
190.59
185.20
190.35
growth rate -10.8% 21.4% -2.8% 2.8%
LT Debt 26.48
26.20
27.39
27.00
growth rate -1.1% 4.5% -0.7%
Equity 488.93
624.79
622.41
641.50
655.09
growth rate 27.8% -0.4% 3.1% 2.1%
Common Shares 0.04
0.04
0.04
0.04
0.04
growth rate 2.9% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Capital Expenditures 10.13
6.72
4.15
3.75
growth rate -33.7% -38.2% -9.6%
Cash Dividends
growth rate
Cash From OA -5.92
-21.69
-3.55
-2.08
-14.37
growth rate 0.0% 0.0% 0.0% 0.0%
Sale Purchase of Stock 0.40
141.50
3.21
0.67
growth rate 35,631.1% -97.7% -54.4%
FCF -16.05
-28.41
-7.70
-5.84
growth rate 0.0% 0.0% 0.0%
Income Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Sales 137.33
105.11
151.08
166.90
169.20
growth rate -23.5% 43.7% 10.5% 1.4%
Op.Income 0.61
-17.65
-20.16
16.66
13.46
growth rate -100.0% 0.0% 100.0% -19.2%
IBT -0.75
-17.03
-19.73
-0.51
12.47
growth rate 0.0% 0.0% 0.0% 100.0%
Net Income 1.43
-11.96
-8.82
3.65
11.84
growth rate -100.0% 0.0% 100.0% 224.5%
Gross Profit 88.01
64.93
90.92
112.71
111.34
growth rate -26.2% 40.0% 24.0% -1.2%
R&D 12.95
22.73
34.92
19.46
18.08
growth rate 75.5% 53.7% -44.3% -7.1%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (11.34)

YOY Growth Grade:

D (35.41)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 681.19 801.80 156.19
EPS / Growth 93.2% 0.30 28.8%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 36.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 28.8% 32.7% 32.7%
Future PE 57.60 110.78 110.78
Future EPS 3.77 5.07 5.07
Value Price
MOS %
53.67
-77.7%
138.88
-42.3%
138.88
-42.3%
MOS Price 26.83 69.44 69.44
IRT 20.49 18.68 18.68

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.